It is estimated that 20-25 percent of individuals have occult HIV infection. It is a substantial public health challenge to identify individuals with undiagnosed HIV and link them to clinical care in the United States. For providers, having this knowledge may affect clinical prognosis and overall patient survival and decrease new infections. However, despite the Center for Disease Control and Prevention (CDC) recommendations, very few providers have incorporated routine HIV testing into their practice. Most often AIDS-defining cancers are used as indicators for targeted HIV screening and non-AIDS-defining cancers are often overlooked in the screening process for HIV.